미국의 셀룰라이트 치료 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 시술별, 셀룰라이트별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. Cellulite Treatment Market Trends:

The U.S. cellulite treatment market size was estimated at USD 570.64 million in 2024 and is expected to grow at a CAGR of 9.7% from 2025 to 2033. The growing preference for cosmetic and aesthetic treatments, along with a surge in obesity rates, is propelling market expansion. Social and psychological challenges linked to obesity such as stigma, weight-based prejudice, emotional distress, and reduced self-confidence are emerging as key drivers. Individuals with obesity frequently encounter bullying, social exclusion, and limited access to educational and employment opportunities. For example, a publication by Novo Nordisk highlights that people with obesity are often discriminated against in professional and academic settings. These societal pressures are significantly contributing to the rising demand for cellulite treatment solutions in the U.S.

Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to American Society of Plastic Surgeons, 25.4 million cosmetic minimally-invasive procedures were carried out in 2023, out of which 0.74 million were Non-invasive fat reduction procedures. Thus, increasing adoption of minimally invasive surgeries, coupled with availability of a wide range of minimally invasive treatment options, is driving the growth of the U.S. cellulite treatment market.

A surge in sedentary lifestyles and obesity has significantly increased the prevalence of cellulite. According to the CDC, nearly 42% of U.S. adults were obese, with many states showing obesity rates exceeding 35%. Excess adipose tissue contributes to the development of cellulite, prompting more individuals to seek cosmetic treatments. This trend is further reinforced by growing health consciousness and a desire for self-care, translating into increased demand for solutions that offer smoother, more toned skin even in the absence of invasive surgery.

Recent years have seen rapid innovation in non-invasive and minimally invasive technologies such as radiofrequency, laser, ultrasound, cryolipolysis, and subcision techniques such as Cellfina offering effective results with minimal downtime. Consumers increasingly favor outpatient procedures and topical/home treatment options that align with busy schedules and ease of access. These technologies, supported by rising disposable incomes and direct-to-consumer education, have made cellulite treatments more mainstream and affordable, significantly driving market expansion.

U.S. Cellulite Treatment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cellulite treatment market report on the basis of procedure, cellulite, and end use:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Non-Invasive Treatment
• Minimally Invasive Treatment
• Topical Treatment
• Cellulite Outlook (Revenue, USD Million, 2021 - 2033)
• Soft Cellulite
• Hard Cellulite
• Edematous Cellulite
• End UseOutlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics and Beauty Centers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. Cellulite
  • 1.2.3. End Use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Procedure outlook
  • 2.2.2. Cellulite outlook
  • 2.2.3. End Use outlook
• 2.3. Competitive scenario

Chapter 3. U.S. Cellulite Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Cellulite Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cellulite Treatment Market: Procedure Estimates & Trend Analysis

• 4.1. Procedure Segment Dashboard
• 4.2. U.S. Cellulite Treatment Market: Procedure Movement Analysis
• 4.3. U.S. Cellulite Treatment Market Size & Trend Analysis, By Procedure, 2021 to 2033 (USD Million)
• 4.4. Non-Invasive Treatment
  • 4.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 4.5. Minimally Invasive Treatment
  • 4.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 4.6. Topical Treatment
  • 4.6.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. U.S. Cellulite Treatment Market: Cellulite Estimates & Trend Analysis

• 5.1. Cellulite Segment Dashboard
• 5.2. U.S. Cellulite Treatment Market: Cellulite Movement Analysis
• 5.3. U.S. cellulite treatment market Size & Trend Analysis, By Cellulite, 2021 to 2033 (USD Million)
• 5.4. Soft Cellulite
  • 5.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 5.5. Hard Cellulite
  • 5.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 5.6. Edematous Cellulite
  • 5.6.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. U.S. Cellulite Treatment Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2024 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, By End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 6.5. Clinics and Beauty Centers
  • 6.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Company market share analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Merz Pharma
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Procedure benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Hologic Inc. (Cynosure)
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Procedure benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Syneron Medical
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Procedure benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Zimmer Aesthetics
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Procedure benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Alma Lasers
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Procedure benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Cymedics
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Procedure benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Nubway
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Procedure benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. AbbVie
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Procedure benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Cutera
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Procedure benchmarking
    • 7.4.9.4. Strategic initiatives